Primary Record
salubrinal
- In stock
- 2,733 g
- Purity
- 98.6 %
- CAS
- 405060-95-9
Compound Identifiers & Properties
- CAS
- 405060-95-9
- PubChem CID
- 5717801
- SMILES
- C1=CC=C(C=C1)/C=C/C(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3
- Canonical SMILES
- O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl
Names & Synonyms
- salubrinal
- 405060-95-9
- Salubrinal?
- eIF-2? Inhibitor
- J8PSF5Z8KJ
- AC1NX1CD
- RefChem:884483
- UNII-J8PSF5Z8KJ
- C21H17Cl3N4OS
- MFCD00548612
- CHEBI:131923
- DTXSID70420852
- eIF-2alpha Inhibitor, Salubrinal
- CHEMBL180127
- orb1304594
- SCHEMBL6477826
- SCHEMBL17360638
- CHEBI:91873
- DTXCID50832434
- LCOIAYJMPKXARU-VAWYXSNFSA-N
- HMS3413G22
- HMS3677G22
- BCP06507
- EX-A2153
- 2699AH
- EBC-50076
- HB0573
- s2923
- STL253110
- BAS 00247559
- AKOS000525027
- AKOS016042385
- CCG-269541
- CID5717801
- CID:5717801
- NCGC00159554-01
- NCGC00159554-09
- AC-33176
- BC600374
- DA-67387
- NS-05839
- SID:85083123
- ST078198
- RT-015629
- SW102000-2
- J2.335.800J
- C75050
- W-5113
- Salubrinal is known as an eIF-2alpha inhibitor.
- (E)-3-phenyl-N-[2,2,2-trichloro-1-(quinolin-8-ylcarbamothioylamino)ethyl]prop-2-enamide
- A873318
- C496827
- N-(2,2,2-trichloro-1-(3-(quinolin-8-yl)thioureido)ethyl)cinnamamide
- (E)-N-(2,2,2-Trichloro-1-(3-(quinolin-8-yl)thioureido)ethyl)cinnamamide
- Q7406268
- (2E)-3-phenyl-N-(2,2,2-trichloro-1-{[(quinolin-8-yl)carbamothioyl]amino}ethyl)prop-2-enamide
- BRD-A45107007-001-02-6
- BRD-A45107007-001-03-4
- BRD-A45107007-001-05-9
- BRD-A77299732-001-01-6
- F0095-1218
- (2E)-3-phenyl-N-[2,2,2-trichloro-1-[[(8-quinolinylamino)thioxomethyl]amino]ethyl]-2-propenamide
- 304475-63-6
- Sal
- (E)-3-phenyl-N-[2,2,2-trichloro-1-(8-quinolylcarbamothioylamino)ethyl]prop-2-enamide
- 3-Phenyl-N-[2,2,2-trichloro-1-[[(8-quinolinylamino)thioxomethyl]amino]ethyl]-2-propenamide
- (2E)-3-PHENYL-N-(2,2,2-TRICHLORO-1-(((8-QUINOLINYLAMINO)THIOXOMETHYL)AMINO)ETHYL)-2-PROPENAMIDE
- (2E)-3-phenyl-N-{2,2,2-trichloro-1-[(quinolin-8-ylcarbamothioyl)amino]ethyl}acrylamide
- (E)-3-phenyl-N-[2,2,2-trichloro-1-(quinolin-8-ylcarbamothioylamino)ethyl]prop-2-enamideEE
- (E)-3-Phenyl-N-[2,2,2-trichloro-1-[3-(8-quinolinyl)thioureido]ethyl]propeneamide
- 3-Phenyl-N-(2,2,2-trichloro-1-(3-(quinolin-8-yl)thioureido)ethyl)acrylamide
- 3-Phenyl-N-[2,2,2-trichloro-1-(3-quinolin-8-yl-thioureido)-ethyl]-acrylamide
- N-[2,2,2-Trichloro-1-(quinolin-8-ylaminocarbamthioyl)ethyl]-(2E)-3-phenylprop-2-enamide
- (2E)-3-phenyl-N-(2,2,2-trichloro-1-{[(8-quinolylamino)thioxomethyl]amino}ethyl )prop-2-enamide
- (2E)-3-phenyl-N-{2,2,2-trichloro-1-[(quinolin-8-ylcarbamothioyl)amino]ethyl}prop-2-enamide
- 137975-06-5
- 2-PROPENAMIDE, 3-PHENYL-N-(2,2,2-TRICHLORO-1-(((8-QUINOLINYLAMINO)THIOXOMETHYL)AMINO)ETHYL)-, (2E)-
- 2-Propenamide, 3-phenyl-N-[2,2,2-trichloro-1-[[(8-quinolinylamino)thioxomethyl]amino]ethyl]-
- 2-Propenamide,3-phenyl-N-[2,2,2-trichloro-1-[[(8-quinolinylamino)thioxomethyl]amino]ethyl]-,(2E)-
- salubrinal|405060-95-9|(E)-3-phenyl-N-[2,2,2-trichloro-1-(quinolin-8-ylcarbamothioylamino)ethyl]prop-2-enamide|N-(2,2,2-trichloro-1-(3-(quinolin-8-yl)thioureido)ethyl)cinnamamide|(2E)-3-phenyl-N-[2,2,2-trichloro-1-[[(8-quinolinylamino)thioxomethyl]amino]ethyl]-2-propenamide|C21H17N4OSCl3|CHEMBL180127|SCHEMBL6477826|SCHEMBL6477833|SCHEMBL17360638|CHEBI:91873|DTXSID70420852|CHEBI:131923|HMS3413G22|HMS3677G22|BCP06507|EX-A2153|MFCD00548612|s2923|STL253110|AKOS000525027|AKOS016042385|CCG-269541|3-Phenyl-N-[2,2,2-trichloro-1-(3-quinolin-8-yl-thioureido)-ethyl]-acrylamide|3-Phenyl-N-[2,2,2-trichloro-1-[[(8-quinolinylamino)thioxomethyl]amino]ethyl]-2-propenamide|NCGC00159554-01|NCGC00159554-09|AC-33176|NS-05839|SW102000-2|C75050|Q7406268|BRD-A77299732-001-01-6|F0095-1218|N-(2,2,2-trichloro-1-(3-quinolin-8-ylthioureido)ethyl)cinnamamide|(E)-N-(2,2,2-Trichloro-1-(3-(quinolin-8-yl)thioureido)ethyl